VCFS International Center
Syracuse, New York, 13210, United States
NCT Number: NCT00916955
The purpose of the project is the determination of how the deletion of DNA from chromosome 22 at the q11.2 band causes the phenotypes observed in velo-cardio-facial syndrome (VCFS). In other words, the purpose remains genotype-to-phenotype matching. Current methods includes the use of whole genome chips and microarray analysis. Blood samples are collected for DNA from every patient who consents from the VCFS Center at Upstate Medical University. They are examined for phenotypic features consistent with our typical clinical evaluation. The information from these examinations will be entered anonymously into a database. Genomic information is then matched to clinical phenotype with appropriate statistical method applied.
Looking for future studies?
Notify MeAll sexes
Observational
Syracuse, New York, 13210, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observe development of syndrome over time
Time frame: 4 years
Time frame: 4 years
State University of New York - Upstate Medical University
Other
Acronym: VCFS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00556530
22q11 Deletion Syndrome, 22q11.2 Deletion Syndrome
New York, United States
View Trial DetailsNCT05149898
22q11 Deletion Syndrome, 22q11.2 Deletion Syndrome
Greenville, South Carolina, United States
View Trial DetailsNCT04647500
22q11 Deletion Syndrome, 22q11.2 Deletion Syndrome
Geneva, Switzerland
View Trial DetailsNCT02895906
22q11 Deletion Syndrome, 22q11.2 Deletion Syndrome
Philadelphia, Pennsylvania, United States
View Trial Details